SUTRO BIOPHARMA INC (STRO)

US8693671021 - Common Stock

4.15  -0.2 (-4.6%)

After market: 4.15 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
153.73M67.77M61.88M42.72M42.74M
Operating Expenses
243.01M196.72M160.40M113.78M98.20M
Research and Development
180.43M137.17M104.40M76.96M65.61M
Selling, General, and Administrative Expenses
62.58M59.54M56.00M36.82M32.59M
Operating Income
-89.28M-128.94M-98.52M-71.06M-55.47M
Interest Income/Expense
13.25M12.24M-7.01M38.93M-280.00K
Other Income/Expense
-12.57MN/AN/AN/AN/A
Income Before Taxes
-88.60M-116.70M-105.54M-32.13M-55.74M
Income Tax
18.19M2.50MN/AN/AN/A
Net Income
-106.79M-119.20M-105.54M-32.13M-55.74M
EBITDA
-82.46M-123.25M-93.68M-66.76M-50.69M
 
Per Share Data
EPS Diluted Total Ops
-1.78-2.35-2.29-0.99-2.43
Non GAAP EPS
-1.78-2.44-2.29-2.46-2.42
 
Statistics
Profit Margin
-69.47%-175.89%-170.56%-75.21%-130.42%
Operating Profit Margin
-58.07%-190.26%-159.21%-166.34%-129.78%

All data in USD

Charts